Feed Preview

Statin Medications & Heart Disease

Statin Medications & Heart Disease diagram by Jatlas2, Wikimedia
Jatlas2, Wikimedia

Statins or HMG-CoA reductase inhibitors, are used clinically to lower cholesterol levels and have been associated with decreased risk of heart disease. Discover the latest research on Statin Medications & Heart Disease here.

Top 20 most recent papers

History of Cardiovascular Disease, Intensive Lifestyle Intervention, and Cardiovascular Outcomes in the Look AHEAD Trial

ObesityJanuary 4, 2020
Look AHEAD Research GroupSusan Z Yanovski
Journal of the American Heart Association

Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy

Journal of the American Heart AssociationDecember 20, 2019
Venu MenonSteven E Nissen
International Journal of Cardiology

Intensified lipid lowering using ezetimibe after publication of the IMPROVE-IT trial: A contemporary analysis from the SPUM-ACS cohort

International Journal of CardiologyDecember 21, 2019
Baris GencerFrançois Mach

Association between rs4149056 variant in SLCO1B1 and early discontinuation of statin after acute myocardial infarction

PharmacogenomicsJanuary 23, 2020
Abdallah Al-SalamehTabassome Simon
European Heart Journal. Acute Cardiovascular Care

Guideline adherence and long-term clinical outcomes in patients with acute myocardial infarction: a Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET) substudy

European Heart Journal. Acute Cardiovascular CareJanuary 25, 2020
Hideki WadaJ-MINUET investigators
Journal of the American Geriatrics Society

Primary Prevention Statins in Older Adults: Personalized Care for a Heterogeneous Population

Journal of the American Geriatrics SocietyJanuary 23, 2020
Deirdre O'NeillDaniel E Forman
Journal of Proteome Research

Lipid profiling of serum and lipoprotein fractions in response to pitavastatin using an animal model of familial hypercholesterolemia

Journal of Proteome ResearchJanuary 23, 2020
Hiroaki TakedaTakeshi Bamba
Cardiovascular Therapeutics

Lipid Lowering Treatment and Eligibility for PCSK9 Inhibition in Post-Myocardial Infarction Patients in Italy: Insights from Two Contemporary Nationwide Registries

Cardiovascular TherapeuticsJanuary 24, 2020
Furio ColivicchiLeonardo De Luca
The Lancet. Diabetes & Endocrinology

Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants

The Lancet. Diabetes & EndocrinologyDecember 22, 2019
Nelson WangSean Lal
Vascular Medicine

Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia: A systematic review and meta-analysis

Vascular MedicineJanuary 23, 2020
Damianos G KokkinidisEhrin J Armstrong
Journal of the American Heart Association

Temporal Trends Analysis of the Characteristics, Management, and Outcomes of Women With Acute Coronary Syndrome (ACS): ACS Israeli Survey Registry 2000-2016

Journal of the American Heart AssociationDecember 20, 2019
Avital PorterAlon Eisen
European Journal of Preventive Cardiology

Estimation of the increased risk associated with recurrent events or polyvascular atherosclerotic cardiovascular disease in the United Kingdom

European Journal of Preventive CardiologyJanuary 23, 2020
Mark D DaneseGuillermo Villa
Clinical Science

SULT2B1b inhibits reverse cholesterol transport and promotes cholesterol accumulation and inflammation in lymphocytes from AMI patients with low LDL-C levels

Clinical ScienceJanuary 21, 2020
Yanan ZhangTiantian Luo
European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery

Early postoperative statin administration does not affect the rate of atrial fibrillation after cardiac surgery

European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic SurgeryJanuary 14, 2020
Jahangir A KhanKati M Järvelä
Bioscience Reports

The influence of iatrogenic atrial septal defect on the prognosis of patients with atrial fibrillation between cryoablation and radiofrequency ablation

Bioscience ReportsJanuary 14, 2020
Ying YangRuiqin Xie
The Journal of Clinical Endocrinology and Metabolism

Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry

The Journal of Clinical Endocrinology and MetabolismJanuary 20, 2020
Viral N ShahT1D Exchange Registry
Open Forum Infectious Diseases

Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate

Open Forum Infectious DiseasesJanuary 18, 2020
Gregory D HuhnMoupali Das

Optimal Medical Therapy on Top of Dual-Antiplatelet Therapy: 1-Year Clinical Outcome in Patients With Acute Coronary Syndrome: The START Antiplatelet Registry

AngiologyDecember 24, 2019
Plinio CirilloRossella Marcucci

Prognostication of Poor Survival After Cardiac Resynchronization Therapy

MedicinaJanuary 18, 2020
Paulius BašinskasTomas Kazakevičius
European Heart Journal

Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006-2015

European Heart JournalDecember 29, 2019
Varun SundaramJennifer K Quint

See more papers from this feed

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

© 2020 Meta ULC. All rights reserved